6-shogaol is more effective than 6-gingerol and curcumin in inhibiting 12-O-tetradecanoylphorbol 13-acetate-induced tumor promotion in mice

Molecular Nutrition and Food Research

Volumn 54, Issue 9, 2010, Pages 1296-1306

  Wu, Hou ^a   Hsieh, Min Chi ^b   Lo, Chih Yu ^c   Liu, Cheng Bin ^d   Sang, Shengmin ^e   Ho, Chi Tang ^a   Pan, Min Hsiung ^b  

^a RUTGERS UNIVERSITY   (United States)

^b NATIONAL KAOHSIUNG UNIVERSITY OF APPLIED SCIENCES   (Taiwan)

^c NATIONAL CHIAYI UNIVERSITY   (Taiwan)

^d KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^e NORTH CAROLINA CENTRAL UNIVERSITY   (United States)

Author keywords

12 O tetradecanoylphorbol 13 acetate; 6 Shogaol; Inflammation; Skin cancer; Two stage skin carcinogenesis

Indexed keywords

ANTINEOPLASTIC AGENT; CATECHOL DERIVATIVE; CURCUMIN; CYCLOOXYGENASE 2; FATTY ALCOHOL; GINGEROL; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; NONSTEROID ANTIINFLAMMATORY AGENT; NOS2 PROTEIN, MOUSE; PTGS2 PROTEIN, MOUSE; SHOGAOL;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECT; FEMALE; GENE EXPRESSION REGULATION; GENETICS; INSTITUTE FOR CANCER RESEARCH MOUSE; METABOLISM; MOUSE; PAPILLOMA; SIGNAL TRANSDUCTION; SKIN; SKIN TUMOR; TOPICAL DRUG ADMINISTRATION; TUMOR VOLUME;

ADMINISTRATION, TOPICAL; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICARCINOGENIC AGENTS; CATECHOLS; CURCUMIN; CYCLOOXYGENASE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; FATTY ALCOHOLS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; MICE; MICE, INBRED ICR; NITRIC OXIDE SYNTHASE TYPE II; PAPILLOMA; RNA, MESSENGER; SIGNAL TRANSDUCTION; SKIN; SKIN NEOPLASMS; TUMOR BURDEN;

MURINAE; MUS;

EID: 77957077028     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.200900409     Document Type: Article

References (47)

1. Manju, V., Nalini, N., Chemopreventive efficacy of ginger, a naturally occurring anticarcinogen during the initiation, post-initiation stages of 1,2 dimethylhydrazine-induced colon cancer. Clin. Chim. Acta 2005, 358, 60-67.
2. Lantz, R. C., Chen, G.J., Sarihan, M., Solyom, A. M. et al., The effect of extracts from ginger rhizome on inflammatory mediator production. Phytomedicine 2007, 14, 123-128.
3. Kikuzaki, H., Ginger for Drug and Spice Purposes, Technomic Publishing Co., Inc., Pennsylvania, USA 2000, pp. 75-105.
4. Ravindran, P. N., Babu, K. N., Ginger: The Genus Zingiber, CRC Press, Boca Raton 2005, pp. 1, 7-15, 115.
5. Govindarajan, V. S. Ginger-chemistry, technology, and quality evaluation: part 2. Crit. Rev. Food Sci. Nutr. 1982, 17, 189-258.
6. Govindarajan, V. S. Ginger-chemistry, technology, and quality evaluation: part 1. Crit. Rev. Food Sci. Nutr. 1982, 17, 1-96.
7. Park, K. K., Chun, K. S., Lee, J. M., Lee, S. S., Surh, Y. J., Inhibitory effects of [6]-gingerol, a major pungent principle of ginger, on phorbol ester-induced inflammation, epidermal ornithine decarboxylase activity and skin tumor promotion in ICR mice. Cancer Lett. 1998, 129, 139-144.
8. Balkwill, F., Coussens, L. M., Cancer: an inflammatory link. Nature 2004, 431, 405-406.
9. Pan, M. H., Lai, C. S., Dushenkov, S., Ho, C. T., Modulation of inflammatory genes by natural dietary bioactive compounds. J. Agric. Food Chem. 2009, 57, 4467-4477.
10. Seo, H. J., Park, K. K., Han, S. S., Chung, W. Y. et al., Inhibitory effects of the standardized extract (DA-9601) of Artemisia asiatica Nakai on phorbol ester-induced ornithine decarboxylase activity, papilloma formation, cyclooxygenase-2 expression, inducible nitric oxide synthase expression and nuclear transcription factor kappa B activation in mouse skin. Int. J. Cancer 2002, 100, 456-462.
11. Chun, K. S., Cha, H. H., Shin, J. W., Na, H. K. et al., Nitric oxide induces expression of cyclooxygenase-2 in mouse skin through activation of NF-kappaB. Carcinogenesis 2004, 25, 445-454.
12. Baldwin Jr, A. S., The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu. Rev. Immunol. 1996, 14, 649-683.
13. Chio, C. C., Chang, Y. H., Hsu, Y. W., Chi, K. H., Lin, W. W., PKA-dependent activation of PKC, p38 MAPK and IKK in macrophage: implication in the induction of inducible nitric oxide synthase and interleukin-6 by dibutyryl cAMP. Cell Signal. 2004, 16, 565-575.
14. Kim, J. M., Oh, Y. K., Lee, J. H., Im, D. Y. et al., Induction of proinflammatory mediators requires activation of the TRAF, NIK, IKK and NF-kappaB signal transduction pathway in astrocytes infected with Escherichia coli. Clin. Exp. Immunol. 2005, 140, 450-460.
15. Chun, K. S., Kim, S. H., Song, Y. S., Surh, Y. J., Celecoxib inhibits phorbol ester-induced expression of COX-2 and activation of AP-1 and p38 MAP kinase in mouse skin. Carcinogenesis 2004, 25, 713-722.
16. Pan, M. H., Hsieh, M. C., Hsu, P. C., Ho, S.Y. et al., 6-Shogaol suppressed lipopolysaccharide-induced up-expression of iNOS and COX-2 in murine macrophages. Mol. Nutr. Food Res. 2008, 52, 1467-1477.
17. Wood, L. C., Jackson, S. M., Elias, P. M., Grunfeld, C., Feingold, K. R., Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice. J. Clin. Invest. 1992, 90, 482-487.
18. Grubauer, G., Feingold, K. R., Elias, P. M., Relationship of epidermal lipogenesis to cutaneous barrier function. J. Lipid Res. 1987, 28, 746-752.
19. Chung, W. Y., Park, J. H., Kim, M. J., Kim, H. O. et al., Xanthorrhizol inhibits 12-O-tetradecanoylphorbol-13-acetate- induced acute inflammation and two-stage mouse skin carcinogenesis by blocking the expression of ornithine decarboxylase, cyclooxygenase-2 and inducible nitric oxide synthase through mitogen-activated protein kinases and/or the nuclear factor-kappa B. Carcinogenesis 2007, 28, 1224-1231.
20. Lai, C. S., Li, S., Chai, C. Y., Lo, C. Y. et al., Inhibitory effect of citrus 5-hydroxy-3,6,7,8,30,40-hexamethoxyflavone on 12-Otetradecanoylphorbol 13-acetate-induced skin inflammation and tumor promotion in mice. Carcinogenesis 2007, 28, 2581-2588.
21. Romashkova, J. A., Makarov, S. S., NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling. Nature 1999, 401, 86-90.
22. Chun, K. S., Cha, H. H., Shin, J. W., Na, H. K. et al., Nitric oxide induces expression of cyclooxygenase-2 in mouse skin through activation of NF-kappaB. Carcinogenesis 2004, 25, 445-454.
23. Israel, A., A role for phosphorylation and degradation in the control of NF-kappa B activity. Trends Genet. 1995, 11, 203-205.
24. Chun, K. S., Kim, S. H., Song, Y. S., Surh, Y. J., Celecoxib inhibits phorbol ester-induced expression of COX-2 and activation of AP-1 and p38 MAP kinase in mouse skin. Carcinogenesis 2004, 25, 713-722.
25. Saleem, M., Afaq, F., Adhami, V. M., Mukhtar, H., Lupeol modulates NF-kappaB and PI3K/Akt pathways and inhibits skin cancer in CD-1 mice. Oncogene 2004, 23, 5203-5214.
26. Chan, K. S., Carbajal, S., Kiguchi, K., Clifford, J. et al., Epidermal growth factor receptor-mediated activation of Stat3 during multistage skin carcinogenesis. Cancer Res. 2004, 64, 2382-2389.
27. Chandrasekharan, N. V., Dai, H., Roos, K. L., Evanson, N. K. et al., COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proc. Natl. Acad. Sci. USA 2002, 99, 13926-13931.
28. Greenhough, A., Smartt, H. J., Moore, A. E., Roberts, H. R. et al., The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment. Carcinogenesis 2009, 30, 377-386.
29. Muller-Decker, K., Furstenberger, G., Neumann, M., Schnolzer, M., Differential protein expression in the epidermis of wild-type and COX-2 transgenic mice. Skin Pharmacol. Physiol. 2006, 19, 89-94.
30. Tiano, H. F., Loftin, C. D., Akunda, J., Lee, C. A. et al., Deficiency of either cyclooxygenase (COX)-1 or COX-2 alters epidermal differentiation and reduces mouse skin tumorigenesis. Cancer Res. 2002, 62, 3395-3401.
31. Muller-Decker, K., Neufang, G., Berger, I., Neumann, M., Marks, F., Furstenberger, G., Transgenic cyclooxygenase-2 overexpression sensitizes mouse skin for carcinogenesis. Proc. Natl. Acad. Sci. USA 2002, 99, 12483-12488.
32. Rundhaug, J. E., Pavone, A., Kim, E., Fischer, S. M., The effect of cyclooxygenase-2 overexpression on skin carcinogenesis is context dependent. Mol. Carcinog. 2007, 46, 981-992.
33. Bol, D. K., Rowley, R. B., Ho, C. P., Pilz, B. et al., Cyclooxygenase-2 overexpression in the skin of transgenic mice results in suppression of tumor development. Cancer Res. 2002, 62, 2516-2521.
34. Wood, L. C., Jackson, S.M., Elias, P.M., Grunfeld, C. et al., Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice. J. Clin. Invest. 1992, 90, 482-487.
35. Pedranzini, L., Leitch, A., Bromberg, J., Stat3 is required for the development of skin cancer. J. Clin. Invest. 2004, 114, 619-622.
36. Lai, C. S., Li, S., Chai, C.Y., Lo, C. Y. et al., Anti-inflammatory and antitumor promotional effects of a novel urinary metabolite, 3',4'-didemethylnobiletin, derived from nobiletin. Carcinogenesis 2008, 29, 2415-2424.
37. Ohori, M., Kinoshita, T., Yoshimura, S., Warizaya, M. et al., Role of a cysteine residue in the active site of ERK and the MAPKK family. Biochem. Biophys. Res. Commun. 2007, 353, 633-637.
38. Boyland, E., Chasseaud, L. F., Enzymes catalysing conjugations of glutathione with alpha-beta-unsaturated carbonyl compounds. Biochem. J. 1968, 109, 651-661.
39. Van, L. C., Van, C. M., Lee, J. J., Jung, S. H., Exploration of essential structure of malloapelta B for the inhibitory activity against TNF induced NF-kappaB activation. Arch. Pharm. Res. 2006, 29, 840-844.
40. Sizemore, N., Lerner, N., Dombrowski, N., Sakurai, H., Stark, G. R., Distinct roles of the Ikappa B kinase alpha and beta subunits in liberating nuclear factor kappa B (NF-kappa B) from Ikappa B and in phosphorylating the p65 subunit of NF-kappa B. J. Biol. Chem. 2002, 277, 3863-3869.
41. Yin, M. J., Yamamoto, Y., Gaynor, R. B., The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta. Nature 1998, 396, 77-80.
42. Surh, Y. J., Lee, S. S., Enzymatic reduction of shogaol: a novel biotransformation pathway for the alpha, beta-unsaturated ketone system. Biochem. Int. 1992, 27, 179-187.
43. Saleem, M., Afaq, F., Adhami, V. M., Mukhtar, H., Lupeol modulates NFskappaB and PI3K/Akt pathways and inhibits skin cancer in CD-1 mice. Oncogene 2004, 23, 5203-5214.
44. Sun, X. F., Zhang, H., NFKB and NFKBI polymorphisms in relation to susceptibility of tumour and other diseases. Histol. Histopathol. 2007, 22, 1387-1398.
45. Murayama, K., Kimura, T., Tarutani, M., Tomooka, M. et al., Akt activation induces epidermal hyperplasia and proliferation of epidermal progenitors. Oncogene 2007, 26, 4882-4888.
46. Carpenter, C. L., Cantley, L. C., Phosphoinositide kinases. Curr. Opin. Cell Biol. 1996, 8, 153-158.
47. Pan, M. H., Hsieh, M. C., Kuo, J. M., Lai, C. S. et al., 6-Shogaol induces apoptosis in human colorectal carcinoma cells via ROS production, caspase activation, and GADD 153 expression. Mol. Nutr. Food Res. 2008, 52, 527-537.